ARTICLE | Company News
Adimab, Gilead deal
April 23, 2012 7:00 AM UTC
Adimab and Gilead partnered to identify therapeutic antibodies against two targets selected by Gilead for an undisclosed indication. Adimab will identify therapeutic leads while Gilead will be respons...